In human cancers, genetic and epigenetic alterations lead to the constitutive high-level expression of Nrf2 [17,28,29,35], which protects cancer cells from the excessive oxidative stress caused by chemotherapies and radiotherapies [33,34]. This evidence concerns the gene NFE2L2 and cancer.